DK164843C - Theophyllin-retardpraeparat og fremgangsmaade til fremstilling heraf - Google Patents

Theophyllin-retardpraeparat og fremgangsmaade til fremstilling heraf

Info

Publication number
DK164843C
DK164843C DK600485A DK600485A DK164843C DK 164843 C DK164843 C DK 164843C DK 600485 A DK600485 A DK 600485A DK 600485 A DK600485 A DK 600485A DK 164843 C DK164843 C DK 164843C
Authority
DK
Denmark
Prior art keywords
retardary
theophyllin
preparing
preparation
theophyllin retardary
Prior art date
Application number
DK600485A
Other languages
Danish (da)
English (en)
Other versions
DK164843B (da
DK600485A (da
DK600485D0 (da
Inventor
Gerald Benedikt
Volker Steinijans
Original Assignee
Byk Gylden Lomberg Chem Fab Gm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gylden Lomberg Chem Fab Gm filed Critical Byk Gylden Lomberg Chem Fab Gm
Publication of DK600485D0 publication Critical patent/DK600485D0/da
Publication of DK600485A publication Critical patent/DK600485A/da
Publication of DK164843B publication Critical patent/DK164843B/da
Application granted granted Critical
Publication of DK164843C publication Critical patent/DK164843C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
DK600485A 1984-12-21 1985-12-20 Theophyllin-retardpraeparat og fremgangsmaade til fremstilling heraf DK164843C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH611184 1984-12-21
CH611184 1984-12-21
CH268385 1985-06-24
CH268385 1985-06-24

Publications (4)

Publication Number Publication Date
DK600485D0 DK600485D0 (da) 1985-12-20
DK600485A DK600485A (da) 1986-06-22
DK164843B DK164843B (da) 1992-08-31
DK164843C true DK164843C (da) 1993-01-11

Family

ID=25691137

Family Applications (1)

Application Number Title Priority Date Filing Date
DK600485A DK164843C (da) 1984-12-21 1985-12-20 Theophyllin-retardpraeparat og fremgangsmaade til fremstilling heraf

Country Status (20)

Country Link
US (1) US4803080A (zh)
EP (1) EP0185331B1 (zh)
KR (1) KR920006910B1 (zh)
CN (1) CN1008060B (zh)
AU (1) AU581274B2 (zh)
BG (1) BG60833B2 (zh)
CA (1) CA1261268A (zh)
CS (1) CS396391A3 (zh)
DE (1) DE3572924D1 (zh)
DK (1) DK164843C (zh)
ES (1) ES8704079A1 (zh)
FI (1) FI84782C (zh)
GR (1) GR853051B (zh)
HU (1) HU193359B (zh)
IE (1) IE58246B1 (zh)
IL (1) IL77322A (zh)
NO (1) NO171827C (zh)
NZ (1) NZ214534A (zh)
PT (1) PT81714B (zh)
SK (1) SK278868B6 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
EP0327295A3 (en) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracycline dosage form
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
ZA200707250B (en) * 2005-01-27 2009-06-24 Alembic Ltd Extended release formulation of levetiracetam
US20080014264A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
RU2631597C2 (ru) 2011-07-15 2017-09-25 Нусерт Сайенсиз, Инк. Композиции и способы модулирования метаболических путей
JP6469015B2 (ja) 2012-11-13 2019-02-13 ニューサート サイエンシーズ， インコーポレイテッド エネルギー代謝を増大させるための組成物および方法
EP2945616B1 (en) 2013-01-15 2018-11-28 NuSirt Sciences, Inc. Treating pulmonary conditions
BR112015023310A2 (pt) 2013-03-15 2017-07-18 Nusirt Sciences Inc composições, métodos e kits para redução de níveis lipídicos
AU2015222754B2 (en) 2014-02-27 2020-06-25 Nusirt Sciences Inc. Compositions and methods for the reduction or prevention of hepatic steatosis
JP6826730B2 (ja) * 2015-04-16 2021-02-10 学校法人 関西大学 抗氷核活性剤
CN106176682A (zh) * 2016-08-30 2016-12-07 铜陵翔宇商贸有限公司 茶碱缓释制胶囊剂及其制备方法
WO2020067887A1 (en) 2018-09-24 2020-04-02 Erasmus University Medical Center Rotterdam Specific inhibition of janus kinase 3 (jak3) for modulating anti-tumor immune responses
GB202001237D0 (en) * 2020-01-29 2020-03-11 Sisteks D O O Granular pharmaceutical product for oral administration from a pre-filled straw and method of manufacturing such pharmaceutical product

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857550A (en) * 1956-01-25 1960-12-29 Lowey Hans Improvements in or relating to the coating of shaped medical preparations
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
WO1983000284A1 (en) * 1981-07-15 1983-02-03 Key Pharma Sustained release theophylline
US4587118A (en) * 1981-07-15 1986-05-06 Key Pharmaceuticals, Inc. Dry sustained release theophylline oral formulation
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung

Also Published As

Publication number Publication date
CA1261268A (en) 1989-09-26
IE853107L (en) 1986-06-21
BG60833B2 (bg) 1996-04-30
NO855215L (no) 1986-06-23
HUT40334A (en) 1986-12-28
CS396391A3 (en) 1992-06-17
KR920006910B1 (ko) 1992-08-22
KR860004634A (ko) 1986-07-11
HU193359B (en) 1987-09-28
NO171827B (no) 1993-02-01
EP0185331A1 (de) 1986-06-25
EP0185331B1 (de) 1989-09-13
AU581274B2 (en) 1989-02-16
NZ214534A (en) 1988-08-30
FI854973A0 (fi) 1985-12-16
DK164843B (da) 1992-08-31
SK278868B6 (sk) 1998-04-08
IL77322A (en) 1990-07-12
DK600485A (da) 1986-06-22
PT81714A (de) 1986-01-01
FI84782C (fi) 1992-01-27
CN1008060B (zh) 1990-05-23
CN85109688A (zh) 1986-06-10
IE58246B1 (en) 1993-08-11
FI854973A (fi) 1986-06-22
DE3572924D1 (en) 1989-10-19
ES550291A0 (es) 1987-04-01
DK600485D0 (da) 1985-12-20
PT81714B (pt) 1988-04-21
US4803080A (en) 1989-02-07
GR853051B (zh) 1986-02-03
ES8704079A1 (es) 1987-04-01
AU5161885A (en) 1986-07-17
FI84782B (fi) 1991-10-15
NO171827C (no) 1993-05-12

Similar Documents

Publication Publication Date Title
NO174473C (no) Fremgangsmåte og ekspresjonsvektor til fremstilling av human TNF
DK70385D0 (da) Bakteriepraeparat og fremgangsmaade til fremstilling deraf
DK491483A (da) Ophthalmisk praeparat og fremgangsmaade til fremstilling heraf
DK164843C (da) Theophyllin-retardpraeparat og fremgangsmaade til fremstilling heraf
DK238988A (da) Fremgangsmaade til fremstilling af 4-acyloxy-3-hydroxyethyl-azetidinoner
DK50889A (da) Cyclomaltodextringlucantransferase og fremgangsmaade til fremstilling heraf
DK185079A (da) Azolopyrimidinoner og fremgangsmaade til fremstilling deraf
DK559387D0 (da) Fremgangsmaade og mellemprodukt til fremstilling af 3-pyrrolidinoler
DK96394A (da) 5-Halogenalkylidinimono-1-arylpyrazoler og fremgangsmåde til fremstilling deraf
DK145885D0 (da) Stroemningsreaktor og fremgangsmaade til fremstilling deraf
DK375085D0 (da) Quinolon-carboxylsyre-derivater og fremgangsmaade til fremstilling deraf
DK379885D0 (da) Antibiotica og fremgangsmaade til fremstilling heraf
DK313785D0 (da) Dihydroorotsyrederivat og fremgangsmaade til fremstilling deraf
DK67786D0 (da) Fremgangsmaade til fremstilling af arylglycidylethere og 3-substituerede 1-alkylamino-2-propanoler
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
PL264722A1 (en) Method of obtaining alkylsulfony-alkyl-chlorobenzenes
DK434984D0 (da) Antibiotisk forbindelse og fremgangsmaade til fremstilling heraf
DK326082A (da) Heptadecapeptid og fremgangsmaade til fremstilling heraf
DK102785A (da) Termostabil pollulanase og fremgangsmaade til fremstilling deraf
DK157205C (da) Bjaelke samt fremgangsmaade til fremstilling heraf
PL265099A1 (en) Method of obtaining stable aerosole preparations
DK555186D0 (da) Dioxolenonestere af cefuroxim og fremgangsmaade til fremstilling heraf
PL141571B2 (en) Method of obtaining nitropigment preparations
PL141572B2 (en) Method of obtaining nitropigment preparations
KR900009686A (ko) N-포르밀-α-L-아스파닐-L-페닐알라닌의 제조방법

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
PUP Patent expired